Yuanyuan Gong

Also affiliated with Shanghai Eye Disease Prevention & Treatment Center, Shanghai First People's Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Intravitreal Gene Therapy with LX102-C01 in Neovascular Age-Related Macular Degeneration: A Phase I Dose-Escalation Study of 12-Month Safety and Efficacy Outcomes”.

Intravitreal Gene Therapy with LX102-C01 in Neovascular Age-Related Macular Degeneration: A Phase I Dose-Escalation Study of 12-Month Safety and Efficacy Outcomes

Ophthalmology Science(2025)10.1016/j.xops.2025.100970

N/A

0DataRank · unranked

0 citations

Mengxi Shen, Jieqiong Chen, Yidong Wu, Yongsheng Zhou, Jingyang Feng +11 more